Skip to main content

Client News

Abivax appoints Michael Ferguson as Chief Commercial Officer

18th April 2023

Medigene AG: New data presented at AACR shows enhanced T cell functionality of MDG1015 in solid tumors

18th April 2023

invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023

18th April 2023

Carbios accelerates its enzyme optimization with screening capabilities for millions of enzymes in a day

18th April 2023

Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis

17th April 2023

InflaRx announces closing of $40 million public offering of ordinary shares

14th April 2023

Heidelberg Pharma AG: Interim management statement on the first three months of 2023

13th April 2023

Destiny Pharma: Audited results for the year ended 31 December 2022

13th April 2023

Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

13th April 2023

Rentschler Biopharma appoints Thomas aus dem Siepen as Global Head Digital Manufacturing and Automation

12th April 2023